FDA device listing

Accuwell T4 Neonatal Screening EIA,BioDominium Diagnostics T4 Neonatal Screening EIA,PRIME T4 Neonatal Screening…

FDA device listing 1497926644 · ASTORIA-PACIFIC, INC.

Key facts

Proprietary names Accuwell T4 Neonatal Screening EIA,BioDominium Diagnostics T4 Neonatal Screening EIA,PRIME T4 Neonatal Screening EIA,SPOTCHECK T4 Neonatal Screening Kit
Owner/operator ASTORIA-PACIFIC, INC.
Owner/operator number 3050015
Premarket submissions K972974
Product codes KLI
Device names KLI - Enzyme Immunoassay, Non-Radiolabeled, Total Thyroxine
Device class Class II
Classification regulations (21 CFR) 862.1700
Review panels Clinical Chemistry
Registered establishments ASTORIA-PACIFIC, INC.
Establishment registrations 3050015
FEI numbers 3050015
Establishment operations Complaint File Establishment, Manufacturer
Registration valid through 2026

At a glance

  • 1–9 Registered establishments listing this device
  • 1–9 UDI devices (GUDID) under the same submission
  • 1–9 Device listings citing the same submission
  • Yes Premarket submission listed

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA device listings

Establishments that make or process devices for the U.S. market must list each device with the FDA. A listing records the device's proprietary names, product codes and premarket submission, and every registered establishment that handles it.

Source: U.S. Food and Drug Administration (FDA), Establishment Registration and Device Listing database

Browse all FDA device listings